Platinum-Montaur Life Sciences
3
2M
2
1
0.33
1
- Stages of investment
- Areas of investment
Summary
The company was established in North America in United States. The leading representative office of defined Corporate Investor is situated in the New York.
Among the various public portfolio startups of the fund, we may underline Echo Therapeutics For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Moreover, a startup needs to be at the age of more than 20 years to get the investment from the fund. Among the most successful fund investment fields, there are Medical Device, Therapeutics.
The fund is constantly included in less than 2 investment rounds annually. The common things for fund are deals in the range of 5 - 10 millions dollars. The important activity for fund was in 2011.
The typical case for the fund is to invest in rounds with 1 participant. In the next rounds fund is usually obtained by Platinum Partners, Medical Technologies Innovation Asia.
Investments analytics
Analytics
- Total investments
- 3
- Lead investments
- 1
- Exits
- 1
- Follow on index
- 0.33
- Investments by industry
- Biotechnology (3)
- Health Care (3)
- Medical (2)
- Pharmaceutical (2)
- Medical Device (1) Show 1 more
- Investments by region
-
- United States (3)
- Peak activity year
- 2011
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 28
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.